Substituted 1,3-diphenylprop-2-en-1-one derivatives and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C549S023000

Reexamination Certificate

active

07943661

ABSTRACT:
The invention concerns novel substituted 1,3-diphenylprop-2-en-1-one derivatives, pharmaceutical compositions comprising same, their therapeutic uses, in particular for treating cerebral ischemia. The invention also concerns a method for preparing said derivatives.

REFERENCES:
patent: 3558612 (1971-01-01), Kuhn et al.
patent: 3994955 (1976-11-01), Sprenger
patent: 4190671 (1980-02-01), Vanstone et al.
patent: 4656305 (1987-04-01), Vanstone et al.
patent: 5109025 (1992-04-01), Satoh et al.
patent: 5276058 (1994-01-01), Satoh et al.
patent: 5326670 (1994-07-01), Kotachi et al.
patent: 5523302 (1996-06-01), Cain et al.
patent: 7385082 (2008-06-01), Delhomel et al.
patent: 7547729 (2009-06-01), Caumont-Bertrand et al.
patent: 7566737 (2009-07-01), Delhomel
patent: 7632870 (2009-12-01), Najib et al.
patent: 2005/0171149 (2005-08-01), Najib et al.
patent: 2005/0176808 (2005-08-01), Najib et al.
patent: 2007/0032543 (2007-02-01), Delhomel et al.
patent: 43 27 365 (1995-02-01), None
patent: 0 947 511 (1999-10-01), None
patent: 1 254 658 (2002-11-01), None
patent: 1 254 759 (2002-11-01), None
patent: 2 248 829 (1975-05-01), None
patent: 2 383 157 (1977-08-01), None
patent: 78 06279 (1978-10-01), None
patent: 2 841 900 (2004-01-01), None
patent: 52078856 (1977-07-01), None
patent: WO 95/05358 (1995-02-01), None
patent: WO 98/27970 (1998-07-01), None
patent: WO 00/23073 (2000-04-01), None
patent: WO 01/98291 (2001-12-01), None
patent: 2004/005233 (2004-01-01), None
patent: 2004/005243 (2004-01-01), None
Byrn, et al. “Solid State Chemistry of Drugs”, 2d ed., SSCI, Inc., Ch. 10 Polymorphs, pp. 232-247 (1999).
Pond et al., caplus an 1906:1190.
Pond et al., caplus an 1906:1190 (1906).
Shibata, “Anti-tumorigenic Chalcones”, Stem Cells, vol. 12, 1994, pp. 44-52.
Dimmock et al, “Bioactivities of Chalcones”, Current Medicinal Chemistry, Bentham Science Publishers, vol. 6, No. 12, 1999, pp. 1125-1149.
L'ebreau et al, “Antioxidant Properties of Di-Tert-Butylhydroylated Flavonoids”, Free Radical Biology and Medicine, vol. 29, No. 9, Nov. 1, 2000, pp. 900-912.
Mukherjee et al, “Synthetic and Biological Activity Evaluation Studies on Novel 1,3-Diarylpropenones”, Bioorganic & Medicinal Chemistry, vol. 9, No. 2, 2001, pp. 337-345.
Cheng et al, “Broussochalcone A, a potent antioxidant and effective suppressor of inducible nitric oxide synthase in lipopolysaccharide-activated macrophages”, Biochemical Pharmacology, vol. 61, No. 8, Apr. 15, 2001, pp. 939-946.
Cheng et al, “Antioxidant properties of butein isolated from Dalbergia odorifera”, Biochemica et Biophysics Acta, vol. 1392, No. 2/3, Jun. 15, 1998. pp. 291-299.
Rajakumar et al, “Antioxidant Properties of Phenyl Styryl Ketones”, Free Radical Research, vol. 22, No. 4, 1995, pp. 309-317.
Arty et al, “Synthesis of benzylideneacetophenones and their inhibition of lipid peroxidation”, European Journal of Medicinal Chemistry 2000 France, vol. 35, No. 4, 2000, pp. 449-457.
Database Chemical Abstracts Service, XP002236011, abstract & Zhang et al, “Antioidation of Peurperia lobate isoflavones”, Tongji Yike Dauxe Xeubao, vol. 26, No. 5, 1997, pp. 340-342.
Stoll et al, Chalcone derivatives antagonize interactions between the human oncoprotein NDM2 and p53, Biochemistry, United States Jan. 16, 2001, vol. 40, No. 2, Jan. 16, 2001, pp. 336-344.
Database Chemical Abstracts Service, XP002262904, abstract & Shi et al, “Synthesis of ethyl Flavone(or chalcone)oxyllsobutyrate and its derivatives as potential antilipidemic agents”, Taiwan Yaoxue Zazhi, vol. 27, No. 1-2, 1975, pp. 12-16.
Lebeau et al, “Beneficial effects of different flavonoids, on functional recovery after ischemia and reperfusion in isolated rat heart”, Bioorganic & Medicinal Chemistry Letters, vol. 11, No. 1, Jan. 8, 2001, pp. 23-27.
Patent Abstracts of Japan vol. 014, No. 126, Mar. 9, 1990 & JP 02 003670 A Jan. 9, 1990.
Halliwell, “Oxidants and the central nervous system: some fundamental questions. Ix oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke?”, Acta Neurologica Scandinavica, Supplementum, Denmark 1989, vol. 126, 1989, pp. 23-33.
Office Action dated Feb. 26, 2009, issued in connection with U.S. Appl. No. 10/520,078.
King, Frank D. “Bioisosteres, Conformational Restriction, and Pro-drugs—Case History: An Example of a Conformational Restriction Approach”, Medical Chemistry: Principles and Practice, 1994, Chapter 14, pp. 206-225.
Byrn, et al, “Solid State Chemistry of Drugs”, 2nded., SSCI, Inc., Chapter 10, p. 232-247, 1999.
Sogawa et al, “3,4-Dihydroxychalcones as Potent 5-Lipoxygenase and Cyclooxygenase Inhibitors”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 36, No. 24, 1993, pp. 3904-3909.
Nakamura et al, “Synthesis and Biological Activities of Fluorinated Chalcone Derivativs”, Bioorganic & Medicinal Chemistry, Elsevier Science Ltd, GB, vol. 10, No. 3, Mar. 2002, pp. 699,706.
Calliste et al, “Chalcones: Structural Requirements for Antioxidant, Estrogenic and Antiproliferative Activities”, Anticancer Research, Helenic Anticancer Institute, Athens, GR, vol. 21, No. 6A, 2001, pp. 3949-3956.
Furman et al, “Di-tert-Butylhydroxylated Flavonoids Protect Endothelial Cells Against Oxidized LDL-Induced Cytotocity”, Journal of Biochemical and Molecular Toxicology, Wiley, New York, NY, US, vol. 15, No. 5, 2001, pp. 270-278.
Lim et al, “Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues”, Journal of Pharmacy and Pharmacology, London, GB, vol. 53, No. 5, May 2001, pp. 653-668.
U.S. Appl. No. 10/520,079, filed Apr. 2005, Najib et al.
U.S. Appl. No. 11/493,040, filed Jul. 2006, Delhomel et al.
Patent Abstracts of Japan, vol. 018, No. 415, Aug. 4, 1994 & JP 06 122623 A, May 6, 1994.
Patent Abstracts of Japan, vol. 012, No. 209, Jun. 15, 1988 & JP 63 010720 A, Jan. 18, 1988.
Haraguchi et al, “Antioxidative and Superoxide Scavenging Activities of Retrochalcones in Glycyrrhiza Inflata”, Bioorganic & Medicinal Chemistry, Elsevier Science Ltd, GB, vol. 6, No. 3, Mar. 1998, pp. 339-347.
Chemical Abstracts Service XP002236041, abstract & Oganesyan et al, “Study of structure-activity (A) interrelations in the flavonoid series. I. Synthesis of chalcome derivatives and quantitative SA analysis”, Khimiko-Farmatseviicheskii Zhurnal, vol. 20, No. 6, 1986, pp. 696-702.
Hsu et al, Structure-Activity Relationships of Substituted Flavonoids. (I), Taiwan-Kexue-Formosanscience, Taipei, TW, vol. 27, No. 1/2, 1973, pp. 23-26.
Szajda et al, “New alkoxycarbonylalkyl oxychalcones and their alpha, beta-dibromo derivatives of potential antimicrobial activity”, Die Pharmazie, Germany, East Mar 1989, vol. 44, No. 3, Mar. 1989. pp. 190-191.
Stoll et al, “Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53”, Biochemistry, American Chemical Society. Easton, PA, US, vol. 40, No. 2, Jan. 16, 2001, pp. 336-344.
Database, Chemical Abstracts Service, XP002271329, abstract & Shi et al, “Synthesis of ethyl flavone (or chalcone) oxyisobutyrate and its derivatives as antilipemic agents”, Taiwan Yaoxue Xazhi, vol. 27, No. 1-2, 1975, pp. 12-16.
Database Chemical Abstracts Service, XP002271330, abstract & Palanowski et al, “Synthesis of potentiao vasoactive compounds. I. phenylacrylophenone derivatives”, Acta Poloniae Pharmaceutica (English Translation), vol. 24, No. 6, 1967, pp. 567-574.
Database, Chemical Abstracts Service, XP002271331, abstract & JP 54 019947 A (Taisho Pharmaceutical Co.) Feb. 15, 1979.
Database, Chemical Abstracts Service, XP002271332, abstract & Safak et al, “Chalcones. II. Synthesis of so

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 1,3-diphenylprop-2-en-1-one derivatives and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 1,3-diphenylprop-2-en-1-one derivatives and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,3-diphenylprop-2-en-1-one derivatives and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2666817

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.